Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Diagnosis DelayedThe Case for Faster Companion Diagnostic Delivery
Oncology Genetics and epigenetics Liquid biopsy Screening and monitoring

Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

From approvals and reimbursement to in-house testing and tissue stewardship - Jane Li discusses the barriers to precision diagnostics, and the route through them

By Helen Bristow 04/02/2026 Interview 7 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Clinical Scorecard: Diagnosis: Delayed – The Case for Faster Companion Diagnostic Delivery

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with specific disease biology requiring targeted therapies.
Care Setting

Key Highlights

  • Highlight the need for education and training for healthcare providers to improve adoption.

Guideline-Based Recommendations

Diagnosis

    Management

    • Integrate biomarker testing into clinical pathways and multidisciplinary discussions, including specific strategies for implementation.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Standard treatments may be less effective without proper biomarker testing, leading to suboptimal patient outcomes.

        Clinical Best Practices

        • Include ongoing education and training for laboratory staff to enhance usability.

        Related Resources & Content

          This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

          Newsletters

          Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

          Newsletter Signup Image

          About the Author(s)

          Helen Bristow

          Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

          More Articles by Helen Bristow

          Explore More in Pathology

          Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

          False

          Advertisement

          Recommended

          False

          Related Content

          A Light in the Darkness
          Liquid biopsy
          A Light in the Darkness

          March 4, 2022

          2 min read

          Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

          Biomarkers: The Bigger Picture
          Liquid biopsy
          Biomarkers: The Bigger Picture

          April 27, 2022

          1 min read

          To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

          Benchmarking… Liquid Biopsy
          Liquid biopsy
          Benchmarking… Liquid Biopsy

          May 13, 2022

          1 min read

          A look at the last five years of publishing on liquid biopsy

          Does Your Blood Know You Have Cancer?
          Liquid biopsy
          Does Your Blood Know You Have Cancer?

          July 25, 2022

          2 min read

          Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

          Affiliations:

          Specialties:

          Areas of Expertise:

          Contributions:

          False

          The Pathologist
          Subscribe

          About

          • About Us
          • Work at Conexiant Europe
          • Terms and Conditions
          • Privacy Policy
          • Advertise With Us
          • Contact Us

          Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.